Prostaglandin E2 Inhibits Alveolar Macrophage Phagocytosis through an E-Prostanoid 2 Receptor-Mediated Increase in Intracellular Cyclic AMP
Open Access
- 1 July 2004
- journal article
- Published by Oxford University Press (OUP) in The Journal of Immunology
- Vol. 173 (1) , 559-565
Abstract
Prostaglandin E2 is a potent lipid mediator of inflammation that effects changes in cell functions through ligation of four distinct G protein-coupled receptors (E-prostanoid (EP)1, EP2, EP3, and EP4). During pneumonia, PGE2 production is enhanced. In the present study, we sought to assess the effect of endogenously produced and exogenously added PGE2 on FcRγ-mediated phagocytosis of bacterial pathogens by alveolar macrophages (AMs), which are critical participants in lung innate immunity. We also sought to characterize the EP receptor signaling pathways responsible for these effects. PGE2 (1–1000 nM) dose-dependently suppressed the phagocytosis by rat AMs of IgG-opsonized erythrocytes, immune serum-opsonized Klebsiella pneumoniae, and IgG-opsonized Escherichia coli. Conversely, phagocytosis was stimulated by pretreatment with the cyclooxygenase inhibitor indomethacin. PGE2 suppression of phagocytosis was associated with enhanced intracellular cAMP production. Experiments using both forskolin (adenylate cyclase activator) and rolipram (phosphodiesterase IV inhibitor) confirmed the inhibitory effect of cAMP stimulation. Immunoblot analysis of rat AMs identified expression of only EP2 and EP3 receptors. The selective EP2 agonist butaprost, but neither the EP1/EP3 agonist sulprostone nor the EP4-selective agonist ONO-AE1-329, mimicked the effects of PGE2 on phagocytosis and cAMP stimulation. Additionally, the EP2 antagonist AH-6809 abrogated the inhibitory effects of both PGE2 and butaprost. We confirmed the specificity of our results by showing that AMs from EP2-deficient mice were resistant to the inhibitory effects of PGE2. Our data support a negative regulatory role for PGE2 on the antimicrobial activity of AMs, which has important implications for future efforts to prevent and treat bacterial pneumonia.Keywords
This publication has 57 references indexed in Scilit:
- Macrophage defences against respiratory tract infectionsBritish Medical Bulletin, 2002
- Inhibition of Phospholipase A2-mediated Arachidonic Acid Release by Cyclic AMP Defines a Negative Feedback Loop for P2Y Receptor Activation in Madin-Darby Canine Kidney D1 CellsJournal of Biological Chemistry, 1999
- Suppressive effect of bronchoalveolar lavage fluid from pigs infected with Mycoplasma hyopneumoniae on chemiluminescence of porcine peripheral neutrophilsVeterinary Immunology and Immunopathology, 1996
- Increased Prostaglandin E2 Production by Concanavalin A-Stimulated Splenocytes of Old MiceGerontology, 1995
- Accelerated Hematopoietic Recovery and Protective Effect of the Cyclooxygenase Inhibitor Indomethacin in Bacterial Infection of Neutropenic MiceCellular Immunology, 1993
- Some mechanisms involved in the prostaglandin E2 immunosuppressive effect in (CBA X C57BL)F1 mice in vivoCellular Immunology, 1990
- Regulation of oxygen radical release from murine peritoneal macrophages by pharmacologic doses of PGE2Free Radical Biology and Medicine, 1987
- Prostaglandin-mediated suppression of macrophage phagocytosis of Listeria monocytogenesCellular Immunology, 1987
- In vivo effects of prostaglandin E2 and arachidonic acid on phagocytosis of fluorescent methacrylate microbeads by rat peritoneal macrophages.Journal of Histochemistry & Cytochemistry, 1982
- Regulation of the immune response by prostaglandinsClinical Immunology and Immunopathology, 1980